Eastern Bankshares, Inc EBC 深 滬
已收盤 10-24 16:00:00 美东时间
17.66
-0.700
-3.81%
華盛通- 最 高18.46
- 今 開18.29
- 成交量 792.64万股
- 最 低 17.35
- 昨 收 18.36
- 總市值 37.26亿
- 52周最高 19.115
- 市盈率 靜 26.91
- 換手率 3.76%
- 52周最低 13.25
- 委 比 99.32%
- 總股本 2.11亿
- 歷史最高 21.15
- 量 比 2.20
- 振 幅 6.05%
- 歷史最低 8.79
- 每 手 1
- 風險率 1.35%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Eastern Bankshares declares $0.13 dividend
Eastern Bankshares (NASDAQ:EBC) declares $0.13/share quarterly dividend. Forward yield 2.83% Payable Dec. 15; for shareholders of record Dec. 3; ex-div Dec. 3. See EBC Dividend Scorecard, Yield Chart,...
10-24 18:22
Eastern Bankshares Q3 Adj. EPS $0.37 Misses $0.42 Estimate, Sales $241.500M Beat $205.932M Estimate
Eastern Bankshares (NASDAQ:EBC) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.42 by 12.11 percent. This is a 48 percent increase over earnings of $0.25 per share from
10-24 04:18
Earnings Scheduled For October 23, 2025
Companies Reporting Before The Bell • Nokia (NYSE:NOK) is estimated to report q...
10-23 16:32
Eastern Bankshares And HarborOne Bancorp Announces That HarborOne Shareholders Have Until 5:00 P.M. ET On October 28, 2025, To Select Their Preferred Merger Consideration
Eastern Bankshares, Inc. ("Eastern") (NASDAQ Global Select Market: EBC), the holding company for Eastern Bank, and HarborOne Bancorp, Inc. ("HarborOne") (NASDAQ Global Select Market: HONE), the holding company for
10-17 04:18
Zentek Announces Its Subsidiary, Albany Graphite Corp Completed Further Material Characterization Tests Under Its Critical Minerals Innovation Fund Grant. Results Confirm That Ultra-High Purity Albany Graphite Meets Nuclear Specifications
("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company, is pleased to share an update from its wholly owned subsidiary, Albany Graphite Corp.
10-06 20:15
Eastern Bankshares Receives Approval for HarborOne Merger
Eastern Bankshares ( ($EBC) ) has issued an announcement. On September 26, 2025...
09-27 05:13
FDA Approves Eli Lilly's Drug For Advanced Breast Cancer
Eli Lilly secured FDA approval for breast cancer drug Inluriyo and EU clearance for Alzheimer's therapy Kisunla following strong Phase 3 data.
09-26 21:12
美股大行评级 | 星展银行上调百度评级至"买入"，目标价177美元；多家机构上调Guardant Health(GH)目标价最高至80美元
今日重点评级关注：Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从12美元升至12.5美元；Oppenheimer：维持Immuneering"跑赢大市"评级，目标价从21美元升至30美元
09-26 09:45
U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor In the Phase 3 EMBER-3 trial, Inluriyo ...
09-26 02:01
TD Cowen Initiates Coverage On Eastern Bankshares with Buy Rating, Announces Price Target of $23
TD Cowen analyst Janet Lee initiates coverage on Eastern Bankshares (NASDAQ: EBC) with a Buy rating and announces Price Target of $23.
09-26 00:09
